⚠️ Partially verified 2026-05-06. Beere 2000 mechanistic claims confirmed via cross-reference to verified hsp70.md. The following remain unverified against full PDF: (1) Anckar 2011 — all HSF1 domain architecture and PTM claims (archive PDF locally available but unread this pass; Read tool was restricted to wiki directory); (2) Morley 2004, Calderwood 2009, Labbadia 2017 — pending download in a local paper archive; (3) WikiPathways WP4846 validity unconfirmed (WebFetch unavailable). Locke 1996, Heydari 1993, Hsu 2003, Akerfelt 2010 confirmed closed-access (not_oa), tagged no-fulltext-access where applicable. See verified-scope for full detail.

Heat-shock response (HSR)

The heat-shock response is a universal eukaryotic transcriptional program activated by proteotoxic stress — including heat, oxidative insults, heavy metals, hypoxia, and the accumulation of misfolded proteins. Its master regulator is the transcription factor hsf1, which trimerizes upon stress, accumulates further in the nucleus (the basal HSF1 pool is already predominantly nuclear), binds heat-shock elements (HSEs) in target gene promoters, and drives rapid, coordinated induction of the major molecular chaperones: hsp70 (HSP72/HSPA1A/HSPA1B), hsp90, hsp60, and the small HSPs including hsp27. The HSR is a central pillar of loss-of-proteostasis biology: its capacity declines markedly with organismal age, and genetic manipulation of HSF1 and its downstream effectors extends or shortens lifespan in multiple model organisms ¹ ².

KEGG note: No standalone KEGG pathway entry exists for the cytosolic HSF1-mediated HSR. KEGG hsa04141 covers the ER unfolded-protein response (unfolded-protein-response), a related but mechanistically distinct program. The Reactome entry R-HSA-3371556 “Cellular response to heat stress” is the most complete curated representation of the canonical HSF1 axis. needs-canonical-id

Mechanism: HSF1 activation cycle

Under unstressed conditions, HSF1 is held as a transcriptionally inactive monomer predominantly in the nucleus (Anckar & Sistonen 2011 p.1091 is explicit on this — the older “HSF1 lives in the cytoplasm at rest” model has been superseded), sequestered by a complex of HSP70 and HSP90 ² ¹. These chaperones act as intracellular stress sensors: when proteotoxic stress generates a surge of misfolded polypeptides, HSP70 and HSP90 are titrated away from HSF1 to service the increased chaperone demand. Freed HSF1 undergoes a three-step activation:

Trimerization — monomeric HSF1 assembles into a homotrimer stabilized by leucine-zipper coiled-coil interactions in the HR-A/B oligomerization domain (HSF1 residues 130–221 per Anckar 2011 Fig 1a — the verified hsf1 page corrected the brief’s “130–230” to 130–221) ¹.
Nuclear accumulation — the trimer accumulates further in the nucleus (small basal nuclear pool already present; activation increases nuclear concentration rather than initiating de-novo cytoplasm→nucleus translocation) and binds nGAAn pentameric repeat sequences (HSEs) in target gene promoters with high cooperativity ¹.
Transactivation — the C-terminal transactivation domain drives Pol II elongation; full activation requires phosphorylation at Ser326 and sumoylation; attenuating phosphorylation at Ser303 and Ser307 limits duration of the response and contributes to stress adaptation ¹.

The response is self-limiting: newly synthesized HSP70 and HSP90 feed back to rebind and repress HSF1, restoring resting-state stoichiometry within ~1–2 hours of continuous mild stress (or upon stress resolution).

Phase	HSF1 state	HSP70/HSP90 occupancy	HSE binding
Basal	Monomer; predominantly nuclear (small cytoplasmic pool)	Bound (repressed)	None
Stress induction	Trimer; nuclear (further enriched)	Released (titrated by misfolded proteins)	High
Attenuation	Monomer; predominantly nuclear	Re-bound (new synthesis)	None

Key downstream effectors

The HSR transcriptome is dominated by molecular chaperones, but also includes co-chaperones, ubiquitin ligases, and autophagy regulators ¹:

Gene / protein	Family	Primary function in the HSR
hsp70 (HSPA1A/HSPA1B)	HSP70	Primary inducible chaperone; prevents aggregation, promotes refolding; inhibits apoptosome assembly ³
hsp90 (HSP90AA1/HSP90AB1)	HSP90	Client-protein stabilization; part of the HSF1-repressing complex at rest
hsp60 (HSPD1)	HSP60/GroEL	Mitochondrial chaperonin; assists folding in mitochondrial matrix
hsp27 (HSPB1)	Small HSPs	ATP-independent holdase; stabilizes actin cytoskeleton; anti-apoptotic
DNAJB1 (HSP40)	HSP40/DNAJ	HSP70 co-chaperone; stimulates ATPase; substrate handoff
BAG3	BAG domain	HSP70 nucleotide-exchange factor; connects chaperones to autophagy

HSP70’s inhibition of apoptosis is mechanistically established: at the apoptosome assembly step, HSP70 binds Apaf-1 (apoptotic protease-activating factor 1) and prevents procaspase-9 recruitment, suppressing caspase cascade activation downstream of cytochrome c release ³.

Connection to downstream pathways

autophagy: BAG3 (a HSP70 co-chaperone induced by HSF1) shuttles terminally misfolded or aggregated clients to autophagic degradation via the CASA (chaperone-assisted selective autophagy) pathway. Elevated HSP70 also indirectly supports autophagy by reducing ER stress and MTOR-suppressing signals. Conversely, mTORC1 inhibition (see mtor) promotes autophagy and cooperates with the HSR to maintain proteostasis — though mechanistic interdependence is incompletely mapped. no-mechanism
apoptosis-pathway: The HSR suppresses apoptosis via multiple HSP effectors. HSP70 inhibits the apoptosome ³; HSP27 blocks cytochrome c-triggered caspase activation upstream. When stress exceeds refolding capacity, the balance tips: prolonged HSF1 activation can paradoxically cooperate with apoptosis in some contexts (cancer biology). The pro-survival vs pro-death toggle is client-load dependent and not fully resolved. contradictory-evidence
unfolded-protein-response: The UPR is the ER-compartment analog of the HSR, regulated by ATF6, IRE1, and PERK rather than HSF1. The two arms are coordinately regulated — ER stress signals can augment cytosolic HSF1 activation via the ISR kinase HRI — but they are distinct programs. See integrated-stress-response for the shared ISR components.

Role in aging

Decline of HSR capacity with age

HSR capacity declines progressively with age in rodents and human cells, contributing to the loss-of-proteostasis hallmark. Key observations:

Rodent skeletal muscle and liver: HSP70 mRNA and protein induction in response to heat stress is reduced ~35% in aged animals compared to young, correlating with decreased HSF1 DNA-binding activity ⁴ ⁵. no-fulltext-access — Locke 1996 and Heydari 1993 are closed-access (not_oa per a local paper archive); quantitative estimates are from cited abstracts and downstream reviews; verify before quoting exact figures.
HSF1 transcriptional attenuation: Aged cells show reduced HSF1 trimerization efficiency and shorter nuclear residency in response to stress — attributed in part to hyperphosphorylation at the inhibitory Ser303/Ser307 sites and to reduced sumoylation at Lys298 ¹. The molecular effectors of age-related HSF1 attenuation are incompletely identified. no-mechanism
Consequence: Reduced HSR capacity means greater accumulation of misfolded and aggregated proteins under conditions (fever, heat, oxidative insults) that young animals handle readily. This creates the positive-feedback dynamic in which failed proteostasis generates further protein aggregation, further titrating residual chaperone capacity.

HSF1 as a longevity regulator (C. elegans)

The most genetically rigorous evidence linking the HSR to lifespan comes from C. elegans:

Overexpression of hsf-1 extends C. elegans lifespan; hsf-1 loss-of-function shortens it and abolishes the thermotolerance phenotype of long-lived daf-2 (insulin/IGF-1 receptor) mutants ⁶. no-fulltext-access — Morley 2004 pending download in a local paper archive; lifespan extension magnitude not verified against full text.
Critically, HSF1 and daf-16 (the FOXO transcription factor) act cooperatively to extend lifespan in daf-2 mutants: both transcription factors are required, and they induce partially non-overlapping transcriptional programs — HSF1 drives chaperone induction; DAF-16 drives metabolic and stress-resistance genes ⁷.
This places the HSR as a required effector of the canonical IIS (insulin/IGF-1 signaling) longevity pathway in C. elegans, rather than a parallel or independent mechanism.

Dimension	Status
Pathway conserved in humans?	yes — HSF1, HSE binding, HSP induction machinery are highly conserved
Phenotype (HSR attenuation with age) conserved in humans?	partial — reduced HSP70 induction in aged human fibroblasts and lymphocytes; quantitative data limited
HSF1 required for IIS lifespan extension in humans?	unknown — genetic experiments not feasible; needs-human-replication

Mitochondrial stress → HSR restoration

In C. elegans, perturbation of mitochondrial function (via clk-1 mutation or mitochondrial UPR induction) restores HSR competence in aged animals, apparently by activating HSF1 via the mitochondrial unfolded-protein response (UPRmt) pathway ⁸. This establishes a mechanistic link between mitochondrial dysfunction (the mitochondrial-dysfunction hallmark) and HSR decline, suggesting that improving mitochondrial proteostasis could partially rescue the age-related attenuation of the HSR. needs-human-replication no-fulltext-access — Labbadia 2017 pending download in a local paper archive; mechanistic detail (specific role of UPRmt in HSF1 reactivation) not verified against full text.

Interventions targeting the HSR

Heat exposure / sauna

Repeated thermal stress (sauna use, hot-tub immersion, mild whole-body heat exposure) activates HSF1 and drives HSP70 induction in humans. See heat-exposure for the evidence base on sauna frequency and cardiovascular/longevity endpoints. The proteostasis-mediated contribution to any observed health benefits is biologically plausible but not mechanistically isolated in current human trials. no-mechanism

Exercise-induced HSF1 activation

Aerobic exercise raises intramuscular temperature and generates reactive oxygen species, both of which activate HSF1 in skeletal muscle. Post-exercise HSP70 induction is a well-documented adaptation. The aging-relevant question — whether exercise-induced HSP70 induction declines with age in proportion to basal HSR attenuation — remains underexplored. needs-replication

Pharmacological HSF1 activators (preclinical)

Several compound classes activate HSF1 by perturbing the HSP90-HSF1 repressive complex or directly inducing proteotoxic stress:

Geranylgeranylacetone (GGA): Induces HSP70 and is neuroprotective in rodent models; oral form used in Japan for peptic ulcer disease. No aging-indication trials.
Celastrol: Triterpene from Tripterygium wilfordii; potent HSF1 activator via inhibiting HSP90 co-chaperone interactions and proteasome function. Preclinical only; systemic toxicity limits translation. needs-human-replication
Arimoclomol: Hydroxylamine derivative; amplifies HSF1 activation at HSEs without independently inducing chaperones; failed Phase 3 in NPC (Niemann-Pick C1); ongoing preclinical work in neurodegeneration. long-term-unknown

HSP90 inhibitors (oncology — note on druggability-tier assignment)

Clinical HSP90 inhibitors (geldanamycin analogs: 17-AAG/tanespimycin, ganetespib, luminespib) target an HSR node with advanced-clinical / late-stage development status — but no HSP90 inhibitor has FDA approval as of 2026 (R27 verifier-corrected from previously-asserted tier 1). All HSP90-inhibitor development has been in oncology, not aging, and the aging-relevant intervention direction — boosting HSR capacity via HSF1 activators — uses the pathway in the opposite direction from HSP90 inhibitors (which suppress it by disabling the client release mechanism). This page carries druggability-tier: 2 per the R26 CLAUDE.md schema clarification: pathway druggability uses the aging-context tier, and the HSR has no FDA-approved aging-indication drug. The CLAUDE.md schema explicitly cites this page as the worked example: “heat-shock-response = tier 2 (HSP90 inhibitors are oncology-only, not aging-validated).” See [[hsp90]] (verified) — the protein page itself was R27-corrected from tier 1 to tier 2 on the same rationale.

Limitations and gaps

Druggability-tier resolved 2026-05-07 (R27 propagation): Per the R26 CLAUDE.md schema clarification, pathway pages use the aging-context druggability tier. HSP90 inhibitors are clinical-stage in oncology only and are anti-HSR (suppressing the pathway), not aging drugs. The aging-relevant direction — HSF1 activation — is preclinical-only (GGA, celastrol, arimoclomol). Tier reset from 1 → 2. The schema explicitly names this page as the worked example for the convention. See hsp90 (verified) — its protein-page tier was R27-corrected on the same basis.
KEGG gap: No standalone KEGG entry for the cytosolic HSF1/HSR axis. hsa04141 (UPR/ER) is the closest but is mechanistically distinct. needs-canonical-id
WikiPathways WP4846 verification: Flagged for re-verification — community entries can drift. Source dates and cross-references should be confirmed in the verification pass. WebFetch was unavailable during the 2026-05-06 verification pass; WP4846 URL validity remains unconfirmed (prior verifier found WP4223 was a 404; same check needed here). needs-canonical-id
Quantitative HSR-decline data in humans: Most human-HSR-attenuation data is from fibroblast and lymphocyte cell cultures, not in vivo. Tissue-specific and age-specific dose-response curves in humans are largely absent. needs-human-replication
Mechanistic basis of age-related HSF1 attenuation: The specific molecular effectors (kinases, deacetylases, co-factor availability) that attenuate HSF1 trimerization in aged cells are incompletely characterized. no-mechanism
HSR-autophagy interdependence: The quantitative and directional relationship between HSR induction and autophagy flux (specifically whether BAG3-mediated CASA is rate-limited by HSF1 activity in aged cells) has not been established by intervention experiments. no-mechanism
Pending local downloads (2026-05-06 verification pass): Morley 2004 (10.1091/mbc.e03-07-0532), Calderwood 2009 (10.1159/000225957), and Labbadia 2017 (10.1016/j.celrep.2017.10.038) were pending download in a local paper archive at time of verification. Run for each; re-verify longevity claims (Morley 2004), mini-review aging context (Calderwood 2009), and UPRmt-HSR restoration mechanistic detail (Labbadia 2017) once PDFs are available.
Anckar 2011 PDF unread this pass: The DOI lookup resolves but Read tool was restricted to the wiki directory during this agent invocation. All Anckar 2011-derived claims — HSF1 domain residue boundaries, trimerization mechanism, PTM sites (Ser326, Ser303, Ser307), sumoylation at Lys298, and attenuation kinetics — remain unverified against the full text. Priority for the next verification pass.

Footnotes

doi:10.1146/annurev-biochem-060809-095203 · Anckar J & Sistonen L · Annu Rev Biochem 2011 · review · model: human/mammalian · locally available PDF (a local paper archive) · canonical reference for HSF1 domain architecture, activation cycle, PTM regulation, and HSR mechanism ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
doi:10.1038/nrm2938 · Akerfelt M, Morimoto RI, Sistonen L · Nat Rev Mol Cell Biol 2010 · review · model: human/mammalian/C. elegans · not_oa (no local PDF) · HSF family biology; HSF1 repression by HSP70/HSP90 complex; aging context ↩ ↩²
doi:10.1038/35019501 · Beere HM et al. · Nat Cell Biol 2000 · in-vitro · model: Jurkat T cell cytosolic extracts (endogenous Hsp70); 293T and MCF-7 cells (Hsp70 overexpression); THP.1 cell lysates; recombinant reconstitution with purified Apaf-1, procaspase-9, and cytochrome c · locally available PDF (a local paper archive; verified on hsp70 R13) · HSP70 inhibits apoptosome assembly by binding Apaf-1 directly (not procaspase-9); prevents procaspase-9 recruitment; HSP70AAAA mutant (C-terminal EEVD-motif alanine substitution) abolished inhibitory activity ↩ ↩² ↩³
doi:10.1379/1466-1268(1996)001<0251:dhsrit>2.3.co;2 · Locke M & Tanguay RM · Cell Stress Chaperones 1996 · in-vivo · model: aged rat myocardium · not_oa (no local PDF) · ~47% reduction in HSF1 DNA-binding activity and ~35% reduction in Hsp72 induction in aged vs young rat heart after heat stress · no-fulltext-access — quantitative estimates from abstract and downstream review citations; verify against full text ↩
doi:10.1128/mcb.13.5.2909 · Heydari AR et al. · Mol Cell Biol 1993 · in-vivo · model: aged rat liver · not_oa (no local PDF) · HSP70 mRNA induction in response to heat stress reduced in aged rats; dietary restriction partially restores induction; transcription-level attenuation no-fulltext-access ↩
doi:10.1091/mbc.e03-07-0532 · Morley JF & Morimoto RI · Mol Biol Cell 2004 · in-vivo · model: C. elegans · download pending in a local paper archive · hsf-1 overexpression extends lifespan; hsf-1 loss-of-function shortens it; thermotolerance of daf-2 mutants requires hsf-1 ↩
doi:10.1126/science.1083701 · Hsu AL, Murphy CT, Kenyon C · Science 2003 · in-vivo · model: C. elegans · not_oa (no local PDF) · HSF1 and DAF-16 cooperate to extend lifespan in daf-2 mutants; both required; non-overlapping transcriptional targets ↩
doi:10.1016/j.celrep.2017.10.038 · Labbadia J et al. · Cell Reports 2017 · in-vivo · model: C. elegans · download pending in a local paper archive · mitochondrial stress (via clk-1 mutation and UPRmt induction) restores HSR competence in aged animals; HSF1 reactivated; proteostasis collapse prevented needs-human-replication ↩

🧬 Aging Wiki

Explorer

heat-shock-response